Elizabeth Mittendorf, Professor of Surgery at Harvard Medical School, shared on LinkedIn:
“I’m returning from Seoul grateful for the opportunity to represent the American Society of Clinical Oncology (ASCO) at the Korean Society of Medical Oncology (KSMO) Annual Meeting – and particularly struck by the strength of the longstanding partnership between our two organizations.
From the moment I arrived, I was met with tremendous warmth by the KSMO leadership and community. My sincere thanks to KSMO President Professor Dong-Wan Kim and the entire KSMO team for the clear commitment they bring to the ASCO-KSMO partnership. Throughout the meeting, there was great evidence of how this relationship translates into meaningful scientific exchange and collaboration.
The ASCO-KSMO joint sessions were a highlight. I was proud to be joined by ASCO colleagues Drs. Michael Lowe, Ravi B. Parikh, and Debra Patt, who shared their expertise and perspectives and helped make our joint sessions such a success. We had terrific engagement around neoadjuvant therapy and an especially thought-provoking discussion of artificial intelligence, including real-world examples of how AI is already transforming oncology practice. The strong attendance and discussion reinforced the value of bringing our communities together to learn from one another.
Cancer is a global challenge. My time in Seoul was a wonderful reminder of what is possible when professional societies build enduring relationships around a shared commitment to improving care for patients with cancer.
Thank you, KSMO, for an outstanding meeting and your continued partnership with ASCO. I look forward to all that we will continue to accomplish together.”
You might be interested in:
7 Powerful Advances in the ASCO 2026 Guideline for Driver-Positive Stage IV NSCLC
